Related Experiment Video
Updated: Jul 19, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
Dendritic cells: emerging roles in tumor immunotherapy
Patricia C Buchsel1, Elaine S DeMeyer
1College of Nursing, Seattle University, Washington, USA. pbuchsel@nwlink.com
Clinical Journal of Oncology Nursing
|October 27, 2006
Summary
Myeloid dendritic cells (DCs) stimulated with granulocyte macrophage-colony-stimulating factor (GM-CSF) show promise as a cancer immunotherapy. These DCs can initiate an immune response against tumors, offering new hope for patients.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Dendritic cells (DCs) are crucial immune cells for initiating T cell responses.
- Cancer immunotherapy aims to harness the immune system to fight cancer.
- Granulocyte macrophage-colony-stimulating factor (GM-CSF) is a cytokine that supports myeloid cell development and function.
Purpose of the Study:
- To examine the role of myeloid DCs in cancer immunotherapy.
- To explore the use of GM-CSF in stimulating DCs for therapeutic cancer vaccines.
- To understand the mechanisms by which GM-CSF-stimulated DCs exert antitumor effects.
Main Methods:
- Stimulation of myeloid DCs from progenitor cells using GM-CSF.
- In vivo and ex vivo approaches for DC maturation and antigen presentation.
- Analysis of DC-mediated immune responses and direct antitumor properties.
Main Results:
- GM-CSF effectively promotes DC maturation, mobilization, and antigen presentation.
- Stimulated DCs can present tumor antigens to T cells, initiating an immune response.
- GM-CSF exhibits additional antitumor effects, including cytotoxicity and antiangiogenesis.
Conclusions:
- Myeloid DCs stimulated with GM-CSF represent a promising strategy for cancer immunotherapy.
- GM-CSF-enhanced DC therapy can activate antitumor immunity and may offer direct cytotoxic benefits.
- Educating oncology nurses about these novel therapies is vital for patient care and hope.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...